MT-201
Anti‑thromboinflammatory indication for vascular inflammation and thrombosis
PreclinicalActive
Key Facts
Indication
Anti‑thromboinflammatory indication for vascular inflammation and thrombosis
Phase
Preclinical
Status
Active
Company
About MabTics
Innovative antibody platform focused on vessel normalization for oncology, vascular, and eye diseases.
View full company profile